Determining the Responsiveness of Intestinal Lipoprotein Production to an Elevation of Plasma Free Fatty Acids
NCT00152945
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Insulin Resistance
Interventions
DRUG:
Intravenous Intralipid
DRUG:
Intravenous leucine, glycerol
Sponsor
University Health Network, Toronto